Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
Statehouse Shift Ahead for Earned Wage Access? In recent years earned wage access apps, which allow workers to obtain access to their earnings before they receive their paychecks, have exploded in popularity...
SD to Consider App- and Device-Based Age Verification Legislation in 2025 The South Dakota Legislature’s Study Committee on Artificial Intelligence and Regulation of Internet Access by Minors voted...
CA Prohibits ‘Captive Audience’ Meetings California Gov. Newsom (D) signed a bill ( SB 399 ) prohibiting businesses from requiring employees to attend employer-sponsored meetings concerning...
CA Enacts Guardrails for Use of AI in Healthcare California Gov. Gavin Newsom (D) signed a pair of bills making the state one of the first to establish guardrails for the use of artificial intelligence...
From Concord, New Hampshire to Sacramento, California and the overwhelming majority of state capitols in between, artificial intelligence has been one of the hottest topics in state legislatures this year...
A bill (SB 410) debated in the Michigan Senate last week would allow residents and state and local governments to sue drug manufacturers and sellers if their products cause injury. In 1995 the state passed the strongest drug immunity law in the nation, shielding drugmakers and sellers almost entirely from such suits. (BRIDGE MICHIGAN)
This year at least 24 states have enacted legislation dealing with health system consolidation and competition, according to the National Conference of State Legislatures. Among many other things the measures address the review and approval of health system mergers, reforms of health system contracting and certificate of need review. (NCSL)
California Gov. Gavin Newsom vetoed a bill (SB 90) that would have prohibited insurers from charging consumers more than $35 out of pocket for a 30-day supply of insulin. Earlier this year the governor announced the state would be partnering with the nonprofit pharmaceutical company Civica Rx to produce its own insulin, which it plans to sell for $30. (ASSOCIATED PRESS, STATE NET)
American taxpayers are overpaying for Medicare Advantage, or Medicare Part C—under which insurance companies are paid by the federal government to manage patient care—by at least $88 billion per year and possibly as much as $140 billion per year, according to a report published by Physicians for a National Health Program. “Various elements of MA, either by design or by consequence, result in a much higher level of government spending than is necessary to provide Medicare benefits, with much of this money going toward corporate profits,” the report states. (MEDICAL ECONOMICS)
—Compiled by SNCJ Managing Editor KOREY CLARK